Search Results 981-990 of 16366 for monoclonal antibody

1. Clinical trials - Oncology (Medical)

   The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

2. SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab - Mayo Clinic

   History of severe hypersensitivity reaction to any monoclonal antibody. Women of Childbearing Potential (WOCBP) who are pregnant or breastfeeding. Women ...

3. A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma - Mayo Clinic

   Monoclonal antibody (ies). At least 28 days since the last dose of monoclonal antibody prior to first dose of tazemetostat. Immunotherapy (e.g., tumor vaccine).

4. Lowering Rejection Risk in Organ Transplants - Mayo Clinic

   Stegall, M.D., Transplantation Surgery, Mayo Clinic: About 80 percent of people who have had a previous transplant have antibodies against other tissue types.

5. MS or not MS? Mayo Clinic Neuroimmunology Lab answers the question

   The AQP4 antibody, discovered at Mayo Clinic in 2004, was the first biomarker associated with inflammatory demyelinating diseases that could be used to ...

6. A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622 - Mayo Clinic

   Participation eligibility · Subjects with any history of hypersensitivity to any monoclonal antibody (including mepolizumab). · Subjects with current malignancy ...

7. A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS - Mayo Clinic

   Previous Treatment with a B-cell depleting antibody; History of severe allergic reactions to humanized or murine monoclonal antibodies; Treatment with any ...

8. Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Monoclonal plasma cells in the bone marrow ≥ 10% at ... Subject has known allergies, hypersensitivity, or intolerance to VELCADE, monoclonal antibodies ...

9. GEN3013, Epcoritamab Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma EPCORE™ NHL-1 - Mayo Clinic

   ... monoclonal antibody-containing therapy. Note: Relapsed disease is defined as disease that has recurred ≥6 months after completion of therapy. Refractory ...

10. Small cell, large cell cancer: What this means - Mayo Clinic

    Monoclonal antibody drugs · Mort Crim and Cancer · Mouth sores caused by cancer treatment: How to cope · MRI · Muscle pain · Needle biopsy · Night sweats · No ...